AlliancePharma Inc. Announces an Exclusive Agreement With the Duval Group and Associates Pharmacists, Holding More Than 14 Pharmacies in Quebec

THETFORD MINES, QUEBEC -- (Marketwired) -- 04/26/16 -- AlliancePharma Inc. (TSX VENTURE: APA) ("AlliancePharma" or "the Company") is pleased to announce an exclusive agreement with the Duval Group and Associates Pharmacists ("Groupe Duval"). The agreement includes an arrangement with 14 pharmacies for replacement pharmacists and pharmacy technicians, and for the use of Logistik Pharma services, a new subsidiary of the Company dedicated to increasing the profitability of pharmacies by optimizing laboratory work organization and patient management. Groupe Duval will also benefit from the virtual teaching platform of AlliancePharma affiliate Elitis Campus for education of their employees.

"AlliancePharma stands out as a leader in pharmacy replacement services, technical assistants in pharmacies and professional services by the recognition of such a mark of confidence and engagement from the Duval Group towards our Company. Our objectives consist in innovation and exceeding our level of services to satisfy all our customers through the implementation of professional services up to their expectations and in line with new market trends", said Marc Lemieux, Chairman of the Board, President and CEO of AlliancePharma.

About AlliancePharma

AlliancePharma is the leader in professional services and replacement pharmacists and pharmacy technicians in Quebec. The quality of its customer service and professional services rendered reflect the expertise of the Company. Management's vision is to expand and diversify its activities to become a key player in the health services industry in Quebec, the rest of Canada and internationally. Additional information regarding the Company is available at www.alliancepharmainc.ca and on SEDAR at www.sedar.com.

This press release contains forward-looking statements to which are associated some risks and uncertainties. Any statement contained in this present press release that does not constitute an historical fact can be considered as a forward-looking statement. Those statements do not warrant as for the future performance of AlliancePharma Inc. and they suppose known and unknown risks as well as uncertainties in such a way that true future perspectives, returns or results of the Company may be different of future returns or results expressed or implied by these forward-looking statements. AlliancePharma Inc. does not accept responsibility for the accuracy and the completeness of those forward-looking statements and does not undertake to publicly review such statements to adapt to new events or circumstance.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contacts:
Patrick Fernet
Global Impact Service g.p.
(514) 796-8787
[email protected]

Source: AlliancePharma Inc.

You May Also Be Interested In

• Apache Corp. (APA) PT Raised to $54 at Susquehanna
• TuminEwap to Collaborate with Japanese Financial Giant, Accelerating Expansion in Asian Markets
• ASTERRA launches first ever API for commercial L-band SAR analytics